The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy.
Ali Asghar OkhovatSoroor AdvaniBentolhoda ZiaadiniAkram PanahiSaeideh SalehizadehShahriar NafissiBahram Haghi AshtianiYusuf A RajaballyFarzad FatehiPublished in: Muscle & nerve (2022)
MUNIX changes correlated with strength and electrophysiological improvements in CIDP patients. This suggests that MUNIX may represent a useful objective biomarker for patient follow-up.